You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The wastewater analytics firm will work with the two government agencies to analyze samples from treatment plants across the US for SARS-CoV-2 viral elements.
The GenomeWeb Index outperformed the Dow Jones, the Nasdaq, and the Nasdaq Biotechnology Index, which all fell in October.
Three US agencies warn of ransomware attacks aimed at hospitals, CBS News reports.
The US Department of Health and Human Services (HHS) said that it would use Fluidigm's saliva-based molecular SARS-CoV-2 test as part of a federal surge testing program.
The firm will deploy 6 million of its rapid point-of-care molecular tests by March 2021, using the money to increase production capacity.
The New York Times reports Nevada has reversed a statewide order directing nursing homes to halt their use of two rapid coronavirus tests.
The awards will support clinical validation, manufacturing, and scale up for SARS-CoV-2 viral antigen and molecular detection.
The option was exercised under a multiyear contract between T2 Bio and BARDA valued at a total of $69 million if all options are exercised.
Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.
The New York Times reports that a series of emails show how Department of Health and Human Services officials sought to silence the Centers for Disease Control and Prevention.
Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.
Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.
Science reports that a Dutch research funding agency is combating a ransomware attack.
In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.